|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma-an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duz MB, Karatas OF, Guzel E, Turgut NF,
Yilmaz M, Creighton CJ and Ozen M: Identification of miR-139-5p as
a saliva biomarker for tongue squamous cell carcinoma: A pilot
study. Cell Oncol (Dordr). 39:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Z, Wang Y, Qiu J, Li Q, Yuan C, Zhang
W, Wang D, Ye J, Jiang H, Yang J and Cheng J: The polycomb group
protein EZH2 is a novel therapeutic target in tongue cancer.
Oncotarget. 4:2532–2549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Canzio D, Larson A and Narlikar GJ:
Mechanisms of functional promiscuity by HP1 proteins. Trends Cell
Biol. 24:377–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan C, Li Z, Qi B, Zhang W, Cheng J and
Wang Y: High expression of the histone demethylase LSD1 associates
with cancer cell proliferation and unfavorable prognosis in tongue
cancer. J Oral Pathol Med. 44:159–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan Y, Li H, Liang X and Xiang Z: CBX3
promotes colon cancer cell proliferation by CDK6 kinase-independent
function during cell cycle. Oncotarget. 8:19934–19946.
2017.PubMed/NCBI
|
|
8
|
Minc E, Courvalin JC and Buendia B:
HP1gamma associates with euchromatin and heterochromatin in
mammalian nuclei and chromosomes. Cytogenet Cell Genet. 90:279–284.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Slezak J, Truong M, Huang W and Jarrard D:
HP1γ expression is elevated in prostate cancer and is superior to
Gleason score as a predictor of biochemical recurrence after
radical prostatectomy. BMC Cancer. 13:1482013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takanashi M, Oikawa K, Fujita K, Kudo M,
Kinoshita M and Kuroda M: Heterochromatin protein 1gamma
epigenetically regulates cell differentiation and exhibits
potential as a therapeutic target for various types of cance. Am J
Pathol. 174:309–316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou J, Bi H, Zhan P, Chang C, Xu C, Huang
X, Yu L, Yao X and Yan J: Overexpression of HP1γ is associated with
poor prognosis in non-small cell lung cancer cell through promoting
cell survival. Tumour Biol. 35:9777–9785. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng X, Jia B, Lin X, Han J, Qiu X, Chu
H, Sun X, Hu W, Pan J, Chen J and Zhao J: FRMD4A: A potential
therapeutic target for the treatment of tongue squamous cell
carcinoma. Int J Mol Med. 38:1443–1449. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Talbot SG, Estilo C, Maghami E, Sarkaria
IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein
R, et al: Gene expression profiling allows distinction between
primary and metastatic squamous cell carcinomas in the lung. Cancer
Res. 65:3063–3071. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Estilo CL, O-charoenrat P, Talbot S, Socci
ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y,
Boyle JO, et al: Oral tongue cancer gene expression profiling:
Identification of novel potential prognosticators by
oligonucleotide microarray analysis. BMC Cancer. 9:112009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuriakose MA, Chen WT, He ZM, Sikora AG,
Zhang P, Zhang ZY, Qiu WL, Hsu DF, McMunn-Coffran C, Brown SM, et
al: Selection and validation of differentially expressed genes in
head and neck cancer. Cell Mol Life Sci. 61:1372–1383. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye H, Yu T, Temam S, Ziober BL, Wang J,
Schwartz JL, Mao L, Wong DT and Zhou X: Transcriptomic dissection
of tongue squamous cell carcinoma. BMC Genomics. 9:692008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suvà ML, Riggi N and Bernstein BE:
Epigenetic reprogramming in cancer. Science. 339:1567–1570. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng W, Ball AR Jr and Yokomori K: HP1:
Heterochromatin binding proteins working the genome. Epigenetics.
5:287–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maison C and Almouzni G: HP1 and the
dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol.
5:296–304. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bártová E, Malyšková B, Komůrková D,
Legartová S, Suchánková J, Krejčí J and Kozubek S: Function of
heterochromatin protein 1 during DNA repair. Protoplasma.
254:1233–1240. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dialynas GK, Vitalini MW and Wallrath LL:
Linking heterochromatin protein 1 (HP1) to cancer progression.
Mutat Res. 647:13–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saini V, Hose CD, Monks A, Nagashima K,
Han B, Newton DL, Millione A, Shah J, Hollingshead MG, Hite KM, et
al: Identification of CBX3 and ABCA5 as putative biomarkers for
tumor stem cells in osteosarcoma. PLoS One. 7:e414012012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lomberk G, Bensi D, Christensen T,
Salisbury J and Urrutia R: HP1 γ has a significant impact on cell
cycle progression through the regulation of G2/M, centrosome
biology and, chromosomal stability in pancreatic cancer cells.
Pancreas. 35:4122007. View Article : Google Scholar
|
|
25
|
Liu M, Huang FF, Zhang D, Ju J, Wu XB,
Wang Y, Wang Y, Wu Y, Nie M, Li Z, et al: Heterochromatin protein
HP1γ promotes colorectal cancer progression and is regulated by
miR-30a. Cancer Res. 75:4593–4604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scully C and Bagan J: Oral squamous cell
carcinoma overview. Oral Oncol. 45:301–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
González-Ramírez I, Soto-Reyes E,
Sánchez-Pérez Y, Herrera LA and García-Cuellar C: Histones and long
non-coding RNAs: The new insights of epigenetic deregulation
involved in oral cancer. Oral Oncol. 50:691–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mascolo M, Siano M, Ilardi G, Russo D,
Merolla F, De Rosa G and Staibano S: Epigenetic disregulation in
oral cancer. Int J Mol Sci. 13:2331–2353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nestorov P, Tardat M and Peters AH:
H3K9/HP1 and Polycomb: two key epigenetic silencing pathways for
gene regulation and embryo development. Curr Top Dev Biol.
104:243–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eguchi T, Calderwood SK, Takigawa M,
Kubota S and Kozaki KI: Intracellular MMP3 promotes HSP gene
expression in collaboration with chromobox proteins. J Cell
Biochem. 118:43–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu H, Wang Y, Li Z, Zhu Y, Zhang W, Wang
D, Lin T, Yang J, Wang Y and Cheng J: Overexpression of suppressor
of zest 12 is associated with cervical node metastasis and
unfavorable prognosis in tongue squamous cell carcinoma. Cancer
Cell Int. 17:262017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun M, Ha N, Pham DH, Frederick M, Sharma
B, Naruse C, Asano M, Pipkin ME, George RE and Thai TH: Cbx3/HP1γ
deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
Sci Rep. 7:428882017. View Article : Google Scholar : PubMed/NCBI
|
